Garo H. Armen - 24 Apr 2026 Form 4 Insider Report for AGENUS INC (AGEN)

Reporting relationship: Chairman, Chief Executive Officer and Principal Financial Officer, Director
Issuer ticker: AGEN
Reported as of: 24 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Apr 2026, 16:15:04 UTC
Prior SEC filing: 21 Apr 2026
Next SEC filing: 05 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Austin Charette, as Attorney-in-Fact for Garo H. Armen

Key filing fact

Garo H. Armen filed Form 4 for AGENUS INC (AGEN) on 28 Apr 2026.

Key facts

This page summarizes Garo H. Armen's Form 4 filing for AGENUS INC (AGEN).
3 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 28 Apr 2026, 16:15.

Change

Previous filing in this sequence was filed on 21 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000935679 Primary reporting owner

ARMEN GARO H

Relationship: Chairman, Chief Executive Officer and Principal Financial Officer, Director
Address: C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON
Signature: /s/ Austin Charette, as Attorney-in-Fact for Garo H. Armen
Signature date: 28 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGEN transaction Derivative

Stock Option

Award

Transaction value
Shares: +1,000,000
Change %
Price: $0.000000^*
Shares after: 1,000,000
Date: 24 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,000,000
Exercise price: $3.90
Footnotes: F1

AGEN transaction Derivative

Stock Option

Award

Transaction value
Shares: +27,750
Change %
Price: $0.000000^*
Shares after: 27,750
Date: 24 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,750
Exercise price: $3.90
Footnotes: F1

AGEN transaction Derivative

Stock Option

Award

Transaction value
Shares: +137,550
Change %
Price: $0.000000^*
Shares after: 137,550
Date: 24 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 137,550
Exercise price: $3.90
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on April 24, 2027, and the balance vesting in equal quarterly installments thereafter.

Footnote F2

Option awarded in lieu of the 2025 annual cash bonus and in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan. Vests in full on May 24, 2026.

SEC remarks

Chairman, Chief Executive Officer and Principal Financial Officer